Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136677013> ?p ?o ?g. }
- W3136677013 endingPage "106" @default.
- W3136677013 startingPage "101" @default.
- W3136677013 abstract "Harnessing natural killer (NK) cell activity, either endogenous NK or NK-cell-based therapy, is in the forefront development for many tumor types. There are compelling clinical evidence demonstrating the significant relevance of loss of NK cell activity with prostate cancer (PCa) disease progression to the lethal phenotype, metastatic castration-resistant PCa (mCRPC). Given that mCRPC is generally regarded as a cold tumor and has only elicited marginal response to immune checkpoint blockade therapy to revive CD8 T cell activity, NK cell targeted therapy may present a viable opportunity not only to directly target mCRPC and also to fire up the cold mCRPC tumor. However, current efforts on harnessing NK cell activity for treating mCRPC is very limited with only one open NK-cell-based clinical trial. This minireview will present the clinical significance of NK cell activity in controlling metastatic PCa and provide perspectives on harnessing NK cell activity for treating mCRPC." @default.
- W3136677013 created "2021-03-29" @default.
- W3136677013 creator A5076095831 @default.
- W3136677013 date "2021-01-01" @default.
- W3136677013 modified "2023-09-26" @default.
- W3136677013 title "Could Harnessing Natural Killer Cell Activity Be a Promising Therapy for Prostate Cancer?" @default.
- W3136677013 cites W1671560425 @default.
- W3136677013 cites W1972814015 @default.
- W3136677013 cites W1978942158 @default.
- W3136677013 cites W1979371667 @default.
- W3136677013 cites W1979811833 @default.
- W3136677013 cites W2051410494 @default.
- W3136677013 cites W2060666846 @default.
- W3136677013 cites W2062135418 @default.
- W3136677013 cites W2085462535 @default.
- W3136677013 cites W2103637402 @default.
- W3136677013 cites W2118991367 @default.
- W3136677013 cites W2185042879 @default.
- W3136677013 cites W2189192330 @default.
- W3136677013 cites W2329107713 @default.
- W3136677013 cites W2332619013 @default.
- W3136677013 cites W2463867199 @default.
- W3136677013 cites W2516362774 @default.
- W3136677013 cites W2531934133 @default.
- W3136677013 cites W2580641909 @default.
- W3136677013 cites W2589172342 @default.
- W3136677013 cites W2600889491 @default.
- W3136677013 cites W2606806612 @default.
- W3136677013 cites W2615520798 @default.
- W3136677013 cites W2741550370 @default.
- W3136677013 cites W2748446253 @default.
- W3136677013 cites W2753621408 @default.
- W3136677013 cites W2754054357 @default.
- W3136677013 cites W2756181170 @default.
- W3136677013 cites W2808503433 @default.
- W3136677013 cites W2903848939 @default.
- W3136677013 cites W2951071083 @default.
- W3136677013 cites W2956054465 @default.
- W3136677013 cites W2967552519 @default.
- W3136677013 cites W2969924938 @default.
- W3136677013 cites W2981185653 @default.
- W3136677013 cites W2982970399 @default.
- W3136677013 cites W2999032994 @default.
- W3136677013 cites W3014592760 @default.
- W3136677013 cites W3025139618 @default.
- W3136677013 cites W3038718086 @default.
- W3136677013 cites W3087526274 @default.
- W3136677013 doi "https://doi.org/10.1615/critrevimmunol.2021037614" @default.
- W3136677013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34348004" @default.
- W3136677013 hasPublicationYear "2021" @default.
- W3136677013 type Work @default.
- W3136677013 sameAs 3136677013 @default.
- W3136677013 citedByCount "3" @default.
- W3136677013 countsByYear W31366770132022 @default.
- W3136677013 countsByYear W31366770132023 @default.
- W3136677013 crossrefType "journal-article" @default.
- W3136677013 hasAuthorship W3136677013A5076095831 @default.
- W3136677013 hasBestOaLocation W31366770132 @default.
- W3136677013 hasConcept C10882517 @default.
- W3136677013 hasConcept C121608353 @default.
- W3136677013 hasConcept C126322002 @default.
- W3136677013 hasConcept C1491633281 @default.
- W3136677013 hasConcept C154317977 @default.
- W3136677013 hasConcept C170493617 @default.
- W3136677013 hasConcept C202751555 @default.
- W3136677013 hasConcept C203014093 @default.
- W3136677013 hasConcept C2777701055 @default.
- W3136677013 hasConcept C2778102761 @default.
- W3136677013 hasConcept C2778468042 @default.
- W3136677013 hasConcept C2780192828 @default.
- W3136677013 hasConcept C502942594 @default.
- W3136677013 hasConcept C54355233 @default.
- W3136677013 hasConcept C55493867 @default.
- W3136677013 hasConcept C71924100 @default.
- W3136677013 hasConcept C86803240 @default.
- W3136677013 hasConcept C8891405 @default.
- W3136677013 hasConceptScore W3136677013C10882517 @default.
- W3136677013 hasConceptScore W3136677013C121608353 @default.
- W3136677013 hasConceptScore W3136677013C126322002 @default.
- W3136677013 hasConceptScore W3136677013C1491633281 @default.
- W3136677013 hasConceptScore W3136677013C154317977 @default.
- W3136677013 hasConceptScore W3136677013C170493617 @default.
- W3136677013 hasConceptScore W3136677013C202751555 @default.
- W3136677013 hasConceptScore W3136677013C203014093 @default.
- W3136677013 hasConceptScore W3136677013C2777701055 @default.
- W3136677013 hasConceptScore W3136677013C2778102761 @default.
- W3136677013 hasConceptScore W3136677013C2778468042 @default.
- W3136677013 hasConceptScore W3136677013C2780192828 @default.
- W3136677013 hasConceptScore W3136677013C502942594 @default.
- W3136677013 hasConceptScore W3136677013C54355233 @default.
- W3136677013 hasConceptScore W3136677013C55493867 @default.
- W3136677013 hasConceptScore W3136677013C71924100 @default.
- W3136677013 hasConceptScore W3136677013C86803240 @default.
- W3136677013 hasConceptScore W3136677013C8891405 @default.
- W3136677013 hasIssue "2" @default.
- W3136677013 hasLocation W31366770131 @default.
- W3136677013 hasLocation W31366770132 @default.
- W3136677013 hasLocation W31366770133 @default.